A detailed history of Mizuho Securities Co. Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mizuho Securities Co. Ltd. holds 100 shares of ABBV stock, worth $20,355. This represents 0.04% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$20,355
% of portfolio
0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $15,479 - $18,076
100 New
100 $17,000
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $242,176 - $272,747
1,760 Added 4400.0%
1,800 $278,000
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $54,771 - $63,406
-410 Reduced 91.11%
40 $5,000
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $98,057 - $122,026
-740 Reduced 62.18%
450 $60,000
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $88,212 - $101,589
610 Added 105.17%
1,190 $189,000
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $1.09 Million - $1.31 Million
-7,881 Reduced 93.15%
580 $93,000
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $614,681 - $704,999
4,580 Added 118.01%
8,461 $1.15 Million
Q2 2022

Jul 21, 2022

BUY
$137.62 - $174.96 $474,926 - $603,786
3,451 Added 802.56%
3,881 $525,000
Q1 2022

Apr 15, 2022

SELL
$131.98 - $163.75 $157,320 - $195,190
-1,192 Reduced 73.49%
430 $70,000
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $126,874 - $160,533
1,181 Added 267.8%
1,622 $220,000
Q3 2021

Nov 05, 2021

BUY
$106.4 - $120.78 $39,474 - $44,809
371 Added 530.0%
441 $48,000
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $946 - $1,054
-9 Reduced 11.39%
70 $8,000
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $2,455 - $2,702
-24 Reduced 23.3%
79 $9,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $8,290 - $11,193
103 New
103 $11,000
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $69,426 - $81,711
-900 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $70,065 - $86,409
900 New
900 $83,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mizuho Securities Co. Ltd. Portfolio

Follow Mizuho Securities Co. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Securities Co. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Securities Co. Ltd. with notifications on news.